JasonComanderMDPhD

Ophthalmology • Boston, MA

Retinal Disease

Massachusetts Eye & Ear Infirmary

Join to view full profile

Dr. Comander is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Comander's full profile

Already have an account?

Office
243 Charles St
Boston, MA 02114
Phone+1 617-573-3529

Education & Training

Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolFellowship, Surgical Retina and Vitreous, 2010 - 2012
Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolResidency, Ophthalmology, 2007 - 2010
Brigham and Women's HospitalInternship, Internal Medicine, 2006 - 2007
Harvard Medical SchoolClass of 2006

Certifications & Licensure

MA State Medical License 2010 - 2026
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

Enhanced Career Development Award Foundation Fighting Blindness
K12 Mentored Clinical Scientist Development Program Award NIH / National Eye Institute, 2012
Career Development Award Research for Prevention of Blindness

Publications & Presentations

PubMed

Phase 1/2 AAV5-hRKp.RPGR (Botaretigene Sparoparvovec) Gene Therapy: Safety and Efficacy in RPGR-Associated X-Linked Retinitis Pigmentosa.
Michel Michaelides, Cagri G Besirli, Yesa Yang, Thales A C DE Guimaraes, Sui Chien Wong
American Journal of Ophthalmology. 2024-11-01
14 citations
Gene Editing for-Associated Retinal Degeneration.
Eric A Pierce, Tomas S Aleman, Kanishka T Jayasundera, Bright S Ashimatey, Keunpyo Kim
The New England Journal of Medicine. 2024-06-06
Structure-based network analysis predicts pathogenic variants in human proteins associated with inherited retinal disease.
Blake M Hauser, Yuyang Luo, Anusha Nathan, Ahmad Al-Moujahed, Demetrios G Vavvas
NPJ Genomic Medicine. 2024-05-27

Journal Articles

Moving Towards PDE6A Gene Supplementation Therapy
Jason Comander, MD, JAMA Ophthalmology
Moving Towards PDE6A Gene Supplementation Therapy
Jason Comander, MD, JAMA Ophthalmology

Press Mentions

Clinical Challenges: Treating Leber Congenital AmaurosisNovember 29th, 2021
CRISPR Used Inside a Person’s Body for the First Time EverMarch 6th, 2020
CLINICAL TRIAL DOWNLOAD: Phase 1/2a Data on Human Retinal Progenitor Cell TherapyMarch 1st, 2020
Join now to see all